顶部联系方式
Have Any Questions? Info@mabspacebio.com
0512-86861701

语言切换

TECHNOLOGY
In Vivo Pharmacology Evaluation
- Categories:Technology
- Time of issue:2018-01-24 00:00:00
- Views:0
MabSpace has established multiple types of models to assess the in vivo efficacy of the immuno-therapeutic antibodies
1) Classic syngeneic models
2) Humanized syngeneic models in which the tumor cells express human PD-L1 e.g. MC38. (see example below)
3) Humannized syngeneic models in which both PD-1 in mice and PD-L1 in tumor cells have been engineered to be human origin
4) PDX tumor implanted in humanized mice resonstituted with CD34+ hematopoietic stem cells
Additional capability has been established for the evaluation of antibody penetration and receptor target occupany in the tumor
Example
Thereaputic humanized syngeneic models in which MC38 tumor cells express human PD-L1 was treated
with PD-L1 blocking antibodies (MSB2311 or MPDL-3280A)
Scan the QR code to read on your phone
页脚关于我们
页脚管道
页脚新闻
页脚人力资源
页脚联系方式
页脚版权
Copyright © 2019 Mabspace Biosciences All rights reserved